ArticleJournal of Cancer2018

Tumor PD-L1 Expression and Clinical Outcomes in Advanced-stage Non-Small Cell Lung Cancer Patients Treated with Nivolumab or Pembrolizumab: Real-World Data in Taiwan.

Shu-Yung Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.